Australian Companies Index: Phile

ACN: 119522039
ABN: 69119522039
Status: Registered
Class: Limited by Shares
Subclass: Proprietary other
Type: Australian proprietary company
ACN: 060671034
ABN: 65060671034
Status: Registered
Class: Limited by Shares
Subclass: Proprietary other
Type: Australian proprietary company
ACN: 008934601
ABN: 35008934601
Status: Registered
Class: Limited by Shares
Subclass: Proprietary other
Type: Australian proprietary company
ACN: 130001722
ABN: 69130001722
Status: Registered
Class: Limited by Shares
Subclass: Proprietary other
Type: Australian proprietary company
ACN: 075015100
ABN: 27075015100
Status: Registered
Class: Limited by Shares
Subclass: Proprietary other
Type: Australian proprietary company
ACN: 007033301
ABN: 92007033301
Status: Registered
Class: Limited by Shares
Subclass: Proprietary other
Type: Australian proprietary company
ACN: 604059225
ABN: 78604059225
Status: Registered
Class: Limited by Shares
Subclass: Proprietary other
Type: Australian proprietary company
ACN: 137486554
ABN: 39137486554
Status: Registered
Class: Limited by Shares
Subclass: Proprietary other
Type: Australian proprietary company
ACN: 153016034
ABN: 12153016034
Status: Registered
Class: Limited by Shares
Subclass: Proprietary other
Type: Australian proprietary company
Filter
2024 © aubiz.net - ABN Lookup, ACN, ABR, ABN Search. All rights reserved.
Contact us: info@aubiz.net
Terms of Use and Privacy Policy

Contains public sector information licensed under the Creative Commons Attribution 3.0 Australia licence. Material on this website was obtained from publicly-accessible databases and is attributed to ©Commonwealth of Australia 2024 (http://data.gov.au, http://acnc.gov.au/ and http://abr.business.gov.au/), ©Intellectual Property Government Open Data 2024, ©ASIC - Company Register. While we try to make the information as precise and up-to-date as possible, we are aware the datasets are not always error-free. Aubiz.net will not take responsibility for any errors in the databases. The material provided should be treated as a starting point of more in-depth research, not as fact.